CHAIF
Commonwealth Healthy Ageing Investment Fund
CHAIF brings together a symbiotic partnership between an exceptional financial partner, Milltrust International & a novel digital evaluation platform which helps to due diligence early-stage companies by using the the collective intelligence of the world’s top healthcare experts, in order to find & invest in the best healthy ageing companies.
Milltrust Ventures is the venture capital branch of Milltrust International Group. It has made over 80 successful private investments over the course of the last decade and today manages circa $500m across a range of funds & syndicated investments. Milltrust is known for its focus on developing countries & investments across the emerging markets landscape, along with its focus on early-stage science & technology with a specific focus on human health, food & agriculture science, impact & sustainability. (www.milltrust.com)
Milltrust operates in partnership with R8ER – the world’s first, professionally vetted, digital evaluation platform for disruptive healthcare that connects technology with investment. Every company is especially reviewed by 5 top healthcare experts including an academic, a clinician, an investor, a regulatory expert & a commercialisation expert. (www.r8er.co.uk)
The CHAIF Structure:
- Fund will be registered & based in Singapore.
- Fund Manager will be Milltrust Ventures, who will be the regulated entity for the provision & management of CHAIF, including the fund set-up, fund structure, ongoing fund management, regulatory licensing, insurance, accounting & auditing, legal & compliance
- Fund size of £50m, funding up to 50 deals with follow on funding available over a 5 year period
- Investment ticket size: £100k to £1m
- Company selection criteria:
- Healthy-ageing related activity/technology or application (company must be based in a Commonwealth country)
- An Incorporated Business
- Formulated, technological concept (Technology Readiness Level as defined by the European Union equal to or more than TRL 2)

